Ciena vs. ADTRAN: Which Optical Networking Stock is the Better Buy?

Ciena is favored over ADTRAN, holding a Zacks Rank #1 versus ADTRAN's #4, supported by accelerating AI-driven optical-networking demand, a book-to-bill ratio above 1, and expected fiscal-2026 backlog exceeding $10 billion. Ciena expects mid-40% gross margins and has won price increases ranging from high single digits to the low-20% range, although component constraints could limit revenue conversion through 2027-28. ADTRAN's cloud, enterprise and government revenue rose 47% year over year and hyperscaler revenue increased 97%, but deployment delays, component shortages, lower-margin product mix and downward earnings-estimate revisions weigh on the outlook; CIEN shares gained 162.3% over the past year while ADTN fell 24.6%.

Analysis

The investable distinction is execution quality under component scarcity, not AI-networking exposure alone. CIEN appears better positioned to pass through cost inflation and prioritize high-value systems, supporting incremental gross-margin expansion; ADTN's mix leaves it absorbing shortages while shipping lower-margin products. The second-order beneficiaries are constrained optical-component vendors such as LITE and COHR, which gain pricing power as equipment makers compete for amplifiers and specialized photonics capacity through 2027.

CIEN's backlog should not be capitalized dollar-for-dollar: customer-requested delivery dates push meaningful conversion beyond the next four quarters, while supply prepayments and inventory commitments can make reported earnings strength diverge from free-cash-flow conversion. After a sharp relative rerating, the near-term risk is not demand collapse but duration risk: any evidence that hyperscaler interconnect capex is being optimized rather than accelerated could compress CIEN's premium multiple before backlog changes. The key 1-3 month catalyst is gross-margin and operating-cash-flow guidance; the 6-18 month catalyst is whether higher-capacity platforms translate into mix-driven earnings rather than merely deferred revenue.

Consensus is likely too dismissive of ADTN's option value from deployment normalization, but that is not yet a long thesis because margin recovery requires both component availability and a better product/customer mix. A supply release could initially hurt CIEN's scarcity premium while disproportionately lifting ADTN shipments and utilization. Conversely, another customer timing revision or gross margin below the low-40% target would confirm that ADTN's problem is competitive positioning rather than temporary fulfillment friction.

Key Decisions for Investors

• Maintain a tactical long CIEN / short ADTN pair for the next 1-2 earnings cycles, sized beta-neutral: CIEN has superior pricing and mix leverage while ADTN remains exposed to shipment timing and margin dilution. Take profits if ADTN guides to sustained gross margin above 42% and sequential Access & Aggregation growth, which would signal the catch-up thesis is becoming real.
• Do not chase CIEN after the rerating; add only on a post-results pullback if management reaffirms backlog conversion and operating cash flow improves alongside margin. Risk-reward is favorable only if cash conversion validates earnings, with a thesis stop on a material reduction in forward revenue guidance or evidence of hyperscaler order deferrals.
• Monitor LITE and COHR as supply-chain confirmation trades rather than immediate recommendations: accelerating component lead times, higher bookings, or explicit price increases would support long exposure over 6-12 months. Avoid entry if capacity additions shorten lead times, as the same normalization would erode supplier pricing power.
• Keep ADTN on a reversal watchlist rather than initiate outright: consider a 6-12 month long only after two signals coincide—customer deployment schedules resume and gross margin returns above 42%. The upside is high operating leverage from under-shipped demand, but the downside remains further estimate cuts if shortages persist without pricing recovery.